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The use of induced pluripotent stem cells (iPSC) derived from independent patients and sources holds
considerable promise to improve the understanding of development and disease. However, optimized use
of iPSC depends on our ability to develop methods to efﬁciently qualify cell lines and protocols, monitor
genetic stability, and evaluate self-renewal and differentiation potential. To accomplish these goals,
57 stem cell lines from 10 laboratories were differentiated to 7 different states, resulting in 248 analyzed
samples. Cell lines were differentiated and characterized at a central laboratory using standardized cell
culture methodologies, protocols, and metadata descriptors. Stem cell and derived differentiated lines
were characterized using RNA-seq, miRNA-seq, copy number arrays, DNA methylation arrays, ﬂow
cytometry, and molecular histology. All materials, including raw data, metadata, analysis and
processing code, and methodological and provenance documentation are publicly available for re-use and
interactive exploration at https://www.synapse.org/pcbc. The goal is to provide data that can improve our
ability to robustly and reproducibly use human pluripotent stem cells to understand development and
disease.
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Design Type(s) parallel group design • cell type comparison design
Measurement Type(s)
phenotype characterization • transcription proﬁling assay • microRNA
proﬁling assay • DNA methylation proﬁling assay • copy number variation
proﬁling
Technology Type(s) pluripotency assay • RNA sequencing • DNA microarray • SNP microarray
Factor Type(s)
culture medium • cloning vector • tissue • cell type • cell line •
germ layer
Sample Characteristic(s)
Homo sapiens • skin of body • induced pluripotent stem cell • umbilical
cord blood • blastocyst • embryonic stem cell • skin of prepuce of penis •
amniotic ﬂuid • bone marrow
Background & Summary
The development of methods to transform adult somatic cells into induced pluripotent stem cells (iPSC)
have lead to new opportunities for disease modeling and clinical translation1–3. While methods of somatic
cell reprogramming are being continually improved4,5, prior to transplantation of iPSC or their
differentiated derivatives, extensive characterization of each line must be performed to ensure normal
growth characteristics, pluripotentiality, genetic stability and lack of immunoreactivity. For comparison
purposes, human embryonic stem cells (hESC) have been considered to be the functional, genetic and
epigenetic ‘gold standard’ in this ﬁeld6. Such analyses are also needed to ensure the reproducible use of
existing iPSC lines for laboratory research purposes.
The Progenitor Cell Biology Consortium (PCBC) of the National Heart, Lung and Blood Institute was
established to investigate and optimize methods for reprogramming and differentiation of iPSC as a
precursor to transplantation studies with these lines. The 64 stem cell lines (58 iPSC and 6 hESC) selected
were obtained from a diverse set of somatic cell of origins, gene reprogramming combinations, culturing
methods (e.g., stromal priming) and reprogramming vectors for both distinct and common genetic
donors. These lines were sent to a centralized core laboratory for cell culturing, mycoplasma testing,
growth characterization, ﬂow cytometry analysis, and in vivo and in vitro differentiation potential. To
provide an unbiased evaluation of PSC stability and quality, we recently characterized 57 of these PSC
lines using a broad range of phenotypic and molecular omics assays7. A single characterization core
laboratory was used to ensure sufﬁcient standardization of these methods. After these characterizations,
57 cell lines were differentiated into 7 different states, including 3 germ layers and embryoid bodies,
and subsequently characterized using genomic assays (CNV, DNA-methylation, mRNA and microRNA)
(Fig. 1).
To ensure the comparability of all identiﬁable covariates, we developed descriptive metadata
standards, including ontology deﬁned controlled vocabularies in addition to consistent quality control
metrics and data analysis methods. All relevant documentation and data has been deposited in Synapse
(https://www.synapse.org/pcbc) (Data Citation 1), a publicly available online collaborative research
platform that provides data annotation, documentation, and ﬁle provenance8. Speciﬁcally, we deposited
metadata, in vitro and in vivo differentiation, qPCR, RNA-seq, miRNA-seq, copy number variation, and
DNA methylation data, and processed results from both low- and high-throughput analyses. An
interactive browser was developed for querying, ﬁltering, analyzing, and visualizing the genomics data.
For users looking to reprocess the raw data, we provide annotations for querying and automatically
downloading all raw and intermediate data ﬁles. We are also using the portal to distribute insights and
results of the analysis as they become available. The data provided is available for unrestricted reuse. We
encourage other researchers and members of the public to download and critically analyze this resource.
Methods
The PCBC Central Cell Characterization Core (C4) established standard protocols for sample collection,
handling, and analysis (syn2512369) and the PCBC Bioinformatics Core established standard data
processing techniques for the multi-omic data as well as computational quality control. The details of
experimental methods for the handling and processing of the stem cells used here have been previously
described7.
Standardization of cell line metadata
The PCBC Bioinformatics Committee Working Group coordinated the development and implementa-
tion of a PCBC cell line characterization metadata standard (syn2767699) for the initially donated cell
lines. Through an iterative process, cell line characterization metadata terms were deﬁned and mapped to
Open Biological and Biomedical Ontologies (OBO) Foundry ontologies9 available through the National
Center for Biomedical Ontology’s (NCBO) BioPortal10. When ontology terms were not sufﬁciently
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deﬁned in their source ontologies, new terms were deﬁned and requested from ontology editors. For
example, cell type terms from the Cell Ontology such as ‘endothelial stem cell’ were added to describe the
cell line type, and cell terms from UBERON were added to describe the cell line’s tissue of origin.
The collected metadata includes detailed information on each associated cell line collected from the
submitting investigators including cell of origin, method of reprogramming, reprogramming gene
combination, donor sex, ethnicity and disease status (syn2767694). Metadata information was initially
provided by the originating laboratory, and was subsequently augmented with in vitro genetic and
experimental characterization data of the line (such as karyotype status), and resubmitted to the
originating lab for conﬁrmation. Metadata ﬁelds have also been added to facilitate sample comparisons in
downstream analyses (see the Usage Notes).
Sample collection and handling
Multiple institutions contributed cell lines used in this study, all of which were generated using IRB-
approved protocols from the initiating institution. Approval letters or designation of non-human subjects
research (for some made with waste products) were received from all institutional IRB. Since no
identifying information on the lines was provided to the C4, this study was performed under an
Embryonic Stem Cell Research Oversight Committee (ESCRO) approval, as it was not considered human
subjects research, and under the IRB at Cincinnati Children's Hospital Research Center.
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Figure 1. Integrated workﬂow for stem cell characterization and data integration. The types of cell lines
evaluated by the PCBC Cell Characterization Core, assays and data processing pipelines are indicated. Numbers
in parentheses indicate number of distinct cell line samples, except at assay level, where they indicate the
number of individual assays (including replicates).
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In brief, hESC and iPSC lines were cultured (using protocols syn2724700 and syn2724705) and stored
(using protocol syn2724707). Each stem cell line was also evaluated in a teratoma assay (protocol
syn3103753) and karyotyped. Reports and images for the teratoma assays (syn2882774) and karyotyping
(syn2679104) are available. The lines were then differentiated into germ layer states: ectoderm, deﬁnitive
endoderm, and mesoderm. The mesoderm differentiation protocol (syn2512371) was adapted from
Zhang et al.11, and samples were taken at 5, 15, and 30 days after differentiation. The ectoderm
differentiation protocol (syn2512373) was adapted from Chambers et al.12. The deﬁnitive endoderm
differentiation protocol (syn2512372) was adapted from D’Amour et al.13. Cells were additionally
differentiated in embryoid body (EB) cultures for 17 days. On day 7, they were grown out from the EB
using the embryoid body differentiation protocol (syn2512370). After differentiation, cells were harvested
for RNA and DNA extraction.
Genomic and epigenetic molecular characterization
In brief, gene and microRNA expression were assessed by Illumina HiSeq 2,000 sequencing, and
methylation was assessed with the Illumina HumanMethylation450 BeadChip. Two assays were used for
copy number variation analysis: 21 cell lines were assayed with the Illumina CytoSNP-850K BeadChip,
and 29 cell lines were assayed with the Illumina HD HumanOMNI-Quad BeadChip platform. For
validation of gene expression, thirty-seven samples were analyzed using a TaqMan Low Density Array
(TLDA) (Stem Cell Pluripotency Array, 43,85,344, Life Technologies) that interogates a panel of stem cell
and pluripotency marker genes (syn3107327).
Data processing
Each assay was processed through one or more reproducible pipelines. Details of the processing for each
ﬁle is stored in Synapse as part of a provenance record for the ﬁle, which links back to code, input ﬁles,
and parameters. Prior to processing, samples with quality control issues (described in the subsequent
assay processing descriptions) were excluded.
RNA-Seq data processing
All samples were evaluated for a variety of quality control metrics including alignment percentage,
proportion of exonic reads, and distribution of reads at the 5′ and 3′ ends of transcripts using the
Cincinnati Children’s Medical Center DNA sequencing core automated pipeline. Samples with quality
control issues (e.g., poor 5′ to 3′ ratios or abnormal karyotype) were ﬂagged in the metadata and were not
included in downstream analyses. FASTQ ﬁles (syn1773112) were aligned to the human genome build
GRCh37 and University of California Santa Cruz (UCSC) transcriptome ref. 14 (syn5663983) using
Tophat 2.0.9 (ref. 15). Quantiﬁcation was performed using two methods. Gene-level reads per kilobase
per million reads (RPKM) values were quantiﬁed using Cufﬂinks 2.0.2 (refs 16,17) with the Ensembl
transcriptome reference (syn5664028) using corrections for sequence-speciﬁc bias and multi-mapped
reads (syn2247799). Also, eXpress 1.4.0 (ref. 18) was used to quantify the transcript level (syn3270268)
using UCSC’s knownGene transcriptome reference (syn3351175). The resulting transcript quantiﬁcations
were summed over transcripts to the gene level for downstream analyses (syn5008587). Alternative
splicing estimates were obtained using AltAnalyze18,19. For AltAnalyze analysis, unique putative novel
exons were determined from all Tophat junction alignments in AltAnalyze version 2.0.9 (ref. 19)
(http://www.altanalyze.org) and analyzed for associated exon-read coverage using the BedTools function
BAMtoBED20, along with all AltAnalyze predicted exons (Ensembl 72 and UCSC annotated mRNAs).
The resulting exon and junction BED ﬁles for AltAnalyze were used as input for downstream statistical
and visualization analyses (clustering, PCA, and network analysis) in AltAnalyze, using indicated
stringency options for transcription, exon and reciprocal junction analyses (syn3105745). These analyses
include reciprocal junction Percent Spliced In (PSI) analysis, in which the ratio of junction read counts
was calculated for each evaluated exon-exon junction compared to the total number of junction read
counts for all genomic overlapping TopHat detected exon-exon junctions (known and novel). Samples
without sufﬁcient junction read-depth (>4 reads) for each evaluated splicing event were not considered
for statistical analyses. For splicing visualization, coverage plots were produced from the Broad’s IGV
Sashimi-Plot function20,21.
miRNA-Seq data processing
miRNA samples were assessed for quality and samples marked as `exclude` had undiagnosed difﬁculties
during sequencing (e.g., only a few miRNAs with aligning reads) and were not used in downstream
analyses. miRNA expression was quantiﬁed with mirExpress v2.1.422 using the human miRBase 20.0
(ref. 23) (syn2247097). miRNA expression was also quantiﬁed with seqbuster24 (syn3355992) using the
human miRBase 21.0 (ref. 23) (syn6185321) of 2,588 annotated miRNAs. The counts for each microRNA
was further ﬁltered to 2,303 miRNAs with at least 2 reads aligned in each mature miRNA. Samples were
considered failing QC that had low overall sequencing read depth of lower than 0.5 million reads and the
percentage of annotated miRNA lower than 20%.
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DNA methylation data processing
DNA-methylation arrays were normalized with the minﬁ R package25 (syn2233188). 15 samples were
removed due to poor intensity identiﬁed by minﬁQC. The remaining samples were quantile normalized
and inspected using principal components analysis.
CNV analysis
The plug-in cnvPartition (v3.2.0) for GenomeStudio was used to identify CNVs from the SNP arrays. For
this software, the default settings were used, with the exception of a minimum loss of heterozygosity was
changed to 5Mb and minimum number of SNPs changed to 10. Microarray copy number ﬁnal reports
were generated (syn2679103).
Genetic analysis
SNPs from the SNP arrays were augmented with SNPs called from RNA-Seq for quality control purposes.
SNPs were called from from RNA-Seq using SamTools 0.1.18 (ref. 26) and subsequently ﬁltered for read
depth using vcftools27 (syn2390898).
Data Records
Data availability overview
All associated data described in this manuscript are available for download at http://www.synapse.org/pcbc
(Data Citation 1). All computationally derived ﬁles also include provenance, a historical record of how,
when, and by whom they were generated, which provides the ability to understand the origin of the
results, reproduce them, apply the same procedures to new data, and attribute the work performed. The
main Project page includes details about the PCBC, overviews of the available data and analyses, and links
to main sections of content. Many individual ﬁles and folders have their own Wiki content as the
equivalent of a ‘README’ ﬁle, providing context and detailed information directly with the content. In
addition to data ﬁles, the analysis code and workﬂows for all associated ﬁles has been included where
appropriate. Analysis scripts are also provided through provenance records tracked with individual ﬁles.
The code and scripts are hosted in Github (https://www.github.com/Sage-Bionetworks/pcbc_c4_analysis)
and are available for reuse under the MIT license. Synapse accession numbers (in the form synXXXX) are
listed with speciﬁc ﬁles and folders directly in the manuscript. Each record also has an associated
Document Object Identiﬁer (DOI) (in the form doi:10.7303/synXXXXX) that can be used for citation.
Each assay (mRNA, miRNA, and methylation) has an associated Folder that contains all raw data ﬁles
(Table 1). Each folder has a Wiki describing the contents and providing direct links to data ﬁles processed
through each assay’s data processing pipeline. Raw data is also available from the NCBI through
BioProject Accession PRJNA338817 (Data Citation 2). High throughput sequencing data for mRNA and
miRNA is available from the Short Read Archive (Data Citation 3), and DNA methylation microarray
data is available from GEO (Data Citation 4). Data and metadata generated by the C4 are available under
a Creative Commons CC0 1.0 Universal license (https://creativecommons.org/publicdomain/zero/1.0/),
meaning they can be used for any purpose without restriction. See the C4 data page
(https://www.synapse.org/#!Synapse:syn1773109/wiki/218833) for further information.
To aid in interactive analyses of this data, a data exploration tool has been developed to facilitate gene-
level and cluster visualization as well as functional enrichment analyses using ToppGene28 This tool is
freely available (with a Synapse account) at https://www.synapse.org/#!Synapse:syn1773109/wiki/63531.
Assay Accession Description
mRNA syn1773112 Raw fastq
syn1773111 Tophat BAM
syn2246521 Cufﬂinks FPKM
syn3270268 eXpress
syn2822494 htseq-count
syn2247799 Summarized FPKM matrix
syn2247543 Summarized eXpress matrices
miRNA syn2247098 Raw fastq
syn2247164 mirExpress
syn2247832 Summarized mirExpress counts matrix
syn5014443 Summarized seqBuster counts matrix
methylation syn2653626 Raw idat
syn2233188 Summarized beta value matrix
Table 1. High level organization of available raw and processed data folders on Synapse for PCBC
samples.
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Metadata collection and standardization
The PCBC cell line metadata standard containing over 100 terms is available (syn2767699). Term
deﬁnitions and URLs for term sources are included. In brief, the top level of terms in each controlled
vocabulary (CV) include: PCBC cell line name, originating laboratory ID, C4 cell line ID, host species, cell
line type, somatic cell type, iPSC cell type of origin, tissue of origin, reprogramming vector type, induced
reprogramming gene combination, culture conditions, donor age, donor life stage, race, ethnicity, sex,
disease, donor phenotype, reprogramming laboratory, and PCBC primary investigator.
Each PCBC cell line term has been deﬁned and linked to an OBO Foundry ontology term, where
available. Ontologies include the NCBI Taxonomy CV, Cell Line Ontology, Cell Ontology, SO: Sequence
Types and Features Ontology, NCI Thesaurus, HsapDv, PATO, the Disease Ontology and the Human
Phenotype Ontology. The metadata characterization of the lines that are undergoing or completed
characterization are available in Synapse (syn2767694). Complete metadata, including speciﬁcs about the
assays (DNA and RNA isloation dates, alignment statistics, etc.) for each assay are also available: mRNA
(syn3156503), miRNA (syn3219876), and methylation (syn3156828).
All assay-related ﬁles have a minimum set of annotations to facilitate programmatic access. First, all
assay ﬁles have a unique identiﬁer (UID) for the speciﬁc assay (generally a combination of the cell line,
differentiation state, replicate, and assay run information). This UID matches up to the records in the
assay metadata tables described above and are used to automate the annotation of the individual ﬁles.
Other annotations are manually added at the time of upload into Synapse. The `dataType` annotation
notes which assay the data ﬁle comes from: mRNA, miRNA, methylation. The `ﬁleType` annotation
denotes the type of ﬁle (e.g., align, bam, bed, count, expr, fastq, fpkm, genomicMatrix, idat, report). Many
ﬁles also have a ﬁle sub-type (e.g., exons, deletions, gene, insertions, isoform, junctions, mapped,
unmapped, channel). These annotations can be used to query for speciﬁc sets of ﬁles, as described below
in the Usage Notes section. This provides the abiliity to easily query (using the Synapse clients) for ﬁles
for a speciﬁc cell line, reprogramming vector, or any other attribute described in the metadata tables. Files
for a speciﬁc cell line across assays can also be identiﬁed (using the dataType annotation) or for a speciﬁc
part of the pipeline process (using the ﬁleType annotation, e.g. ‘bam’ for aligned reads in the BAM
format). Example queries are provided below in the Usage Notes section.
Experimental protocols
Experimental protocols used in the processing of C4 cell lines are available for public use (syn2512369).
These include protocols for handling, storing, and differentiating stem cells. Furthermore, 5 hub sites of
the PCBC have also contributed 23 protocols used in their own laboratories for the processing, handling,
and induction of stem cells. Each of these protocols are annotated with the lab from where the samples
originated and, if available, the individual scientists who the protocol should be attributed to. Each
protocol has a DOI so future use of the protocol can be cited and attributed to the lab and individuals
responsible for it’s creation.
Cell line pages
We have automatically generated curated pages (syn5762789) for each of the publicly available C4 cell
lines which contains cell line and assay metadata as well as summaries and tables of links to all raw and
derived ﬁles for the speciﬁc line in Synapse. Each page has a DOI for use in citation. Physical samples of
cell lines have been depositied with WiCell Research Institute (www.wicell.org). Links to WiCell are being
generated to be able to order the cell lines, as well as links from WiCell back to Synapse for access to
derived data.
Technical Validation
Conﬁrmation of cell line donor
Donor gender was conﬁrmed by karyotyping (syn2679104), and lines originating from a common donor
were identiﬁed using SNPs from arrays and RNA-Seq (see Methods) through an identity-by-descent
analysis with PLINK29, which identiﬁed three samples with unannotated common donors (syn6185100).
Validation of genomics characterization
All samples were evaluated for a variety of quality control metrics including alignment percentage,
proportion of exonic reads, and distribution of reads at the 5′ and 3′ ends of transcripts using the
Cincinnati Children’s Medical Center DNA sequencing core automated pipeline. Outlier samples with
poor 5′ to 3′ ratios or other clear quality control issues were ﬂagged and were not included in
downstream analyses. For the remaining samples we performed an assesment of the technical and
biological signals to both assess samples affected by signiﬁcant technical issues (e.g., sequence read depth,
RNA-quality, probe detection P-values) as well as determine covariates that would contribute
signiﬁcantly to any downstream analysis (mRNA: syn5008937; miRNA: syn5014447; methylation:
syn4486559). We utilized principal component analysis (PCA) and hierarchical clustering as a primary
modes of assessing potential variability and major class differences among each of the analyses
differentiation states (Fig. 2).
In general, these analyses indicate that there is relative consistency in the expression and methylation
proﬁles obtained from these diverse datasets, as best indicated by PCA. The largest degree of variability is
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associated with the differentiation state of the cells with contributions from patient gender, type of cell
line (hESC versus iPSC) and speciﬁc donor among other signals. These analyses indicate that samples are
most similar among differentiation states, suggesting this data is suitable for covariate associated
comparison analyses.
Usage Notes
Data access and navigation
There are multiple routes for accessing the stored data: 1) web-based ﬁle navigation, 2) programmatic
access (Python, R, command line, or Java), 3) interactive gene queries and visualization, and 4) signature
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Figure 2. Principal components analysis of mRNA, miRNA, and methylation features. The ﬁrst two PCs
are shown, with sample points colored by the differentiation state.
Figure 3. Screenshot of the interactive data explorer of the PCBC data. The mRNA, miRNA, and
methylation data, along with the associated metadata, are queryable. Users can also search across assays
(for example, miRNAs that may target genes). Data can be downloaded for further use.
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enrichment analysis in ToppGene. All data ﬁles can be accessed through the Synapse web interface to
select individual ﬁles or directories of ﬁles containing the described materials. All ﬁles contain provenance
tracking information associating each result ﬁle with its associated raw formatted ﬁle, analysis
scripts used for processing, version of software used, protocols, and metadata. This same data can be
accessed using the Synapse clients (https://github.com/Sage-Bionetworks/synapsePythonClient,
https://github.com/Sage-Bionetworks/rSynapseClient/) via the indicated Synapse accession numbers or
by querying the associated metadata annotations. Examples are included for quality control and
normalization of this data using IPython Notebooks and R Markdown documents for many of
the provided accession numbers. Documentation about Synapse, including the clients, is available at
http://docs.synapse.org/.
Interactive and exploratory analyses
An online application using the R package ‘shiny’ has been developed for interactive exploration of gene,
miRNA or DNA-methylation signatures (https://www.synapse.org/#!Synapse:syn1773109/wiki/63531)
(Fig. 3). We provide the ability to ﬁlter data based on metadata terms (cell type, reprogramming
conditions, differentiation state, etc.) as well as on features (genes, miRNAs, or methylation probes).
The main visualization of the data is a heatmap of expression values (or probe intensities for methylation
arrays). We use publicly available records of interactions between genes and miRNAs (syn3461627),
genes and methylation probes (syn2775255), and miRNAs and methylation probes (syn4895962) to link
together different assays. For example, a user can provide a list of genes and visualize the
expression patterns of the miRNAs that potentially target them; or, by providing a list of miRNAs,
vizualize the expression of the potential target genes. Features with correlated expression patterns with
the user-selected features can be optionally included automatically through a user-deﬁned threshold of
similarity. We include the ability to select gene sets based on pathways from KEGG30,31 and
Reactome32,33. The heatmap can be customized using user-adjustable options for the clustering of
samples or features. The underlying expression values can be directly viewed or downloaded for further
analysis as text-based comma separated value ﬁles. Lastly, a direct link to the software suite ToppGene28
for gene set enrichment analysis of user-selected features is provided. The R code for the Shiny
application is also freely available for reuse and modiﬁcation at https://github.com/Sage-Bionetworks/
PCBCDataExplorer.
Querying Synapse
All assay ﬁles in this project are annotated to facilitate ﬁnding them with the information from the
metadata tables. For example to ﬁnd all mRNA fastq ﬁles originating from CD34+ cells (restricted to
the PCBC project, syn1773109), we use a Synapse query from one of the clients. For example, from the
command line client (which comes with the Python client):
synapse query "select * from syn7511263 where dataType=mRNA AND
fileType=fastq AND Cell_Type_of_Origin=’CD34+ cells’"
Similarly in Python:
import synapseclient
syn=synapseclient.login()
results=syn.tableQuery("select * from syn7511263 where
dataType=mRNA AND fileType=fastq AND
Cell_Type_of_Origin=’CD34+ cells’")
or in the R client:
library(synapseClient)
synapseLogin()
results o- synTableQuery("select * from syn7511263 where
dataType=mRNA AND fileType=fastq AND
Cell_Type_of_Origin=’CD34+ cells’")
Data availability
The raw and normalized data products are provided as open-access data without any usage constraints or
licensing required, as per the Synapse end-user access agreement. A free Synapse account (https://www.
synapse.org/register) is required for downloading the available ﬁles.
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